1636 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
22 Unknown  Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation
Conditions: Mediastinal Lymphadenopathies;   Mediastinal Masses;   Hilar Lymphadenopathies
Intervention:
23 Unknown  Dx Mediastinal Malignant LAP:Compare PET and EBUS-TBNA
Condition: Mediastinal Lymphadenopathy
Intervention: Procedure: PET and EBUS-TBNA
24 Unknown  Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
Conditions: Mediastinal Lymphadenopathy;   Hilar Lymphadenopathy;   Lymphoma;   Lung Neoplasms;   Sarcoidosis
Intervention: Device: EBUS-TBNA
25 Recruiting Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
Conditions: Pancreatic Tumor;   Gastric Tumor;   Esophageal Tumor;   Lymphadenopathy;   Duodenal Tumor
Intervention: Procedure: Endoscopic ultrasound guided needle tissue acquisition.
26 Recruiting Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Conditions: Lymphedema;   Breast Cancer
Intervention: Device: Flexitouch
27 Recruiting Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Conditions: Leukemia;   Myelodysplastic Syndrome;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG);   Procedure: Stem Cell Transplant;   Procedure: Stem Cells Collections;   Drug: Fludarabine, Thiotepa, Antithymocyte globulin (ATG), and Total Body Irradiation (TBI);   Drug: Fludarabine, Busulfan, and ATG
28 Recruiting Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
Conditions: Hodgkin Lymphoma;   Diffuse Large B-Cell Lymphoma
Interventions: Drug: Cylcophosphamide;   Drug: Etoposide;   Drug: Alemtuzumab;   Drug: Doxorubicin;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Rituximab;   Drug: Vincristine
29 Recruiting Stem Cell Collection With Ofatumumab
Condition: Lymphoma
Interventions: Drug: Ofatumumab;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Mesna;   Drug: G-CSF;   Procedure: Stem Cell Collection
30 Recruiting R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukaemia;   Small Lymphocytic Lymphoma
Interventions: Drug: Rituximab;   Drug: Cladribine
31 Unknown  The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
Condition: Breast Cancer
Intervention: Device: Garment Sleeve
32 Recruiting An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention: Drug: Ofatumumab with GSK2110183
33 Recruiting National Breast Cancer and Lymphedema Registry
Conditions: Breast Cancer;   Lymphedema
Intervention:
34 Recruiting Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients
Condition: B-Cell Lymphomas
Intervention: Drug: Ofatumumab
35 Recruiting Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
Conditions: Burkitt's Lymphoma;   High-grade B-cell Lymphoma
Intervention: Other: No intervention (observational study)
36 Recruiting CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Conditions: Chronic Myeloid Leukemia (CML);   Acute Myelogenous Leukemia (AML);;   Myelodysplastic Syndrome (MDS);;   Juvenile Myelomonocytic Leukemia (JMML);;   Acute Lymphoblastic Leukemia (ALL);;   Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: Device: CliniMACS CD34+ Reagent System;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Alemtuzumab;   Drug: Tacrolimus;   Drug: Melphalan;   Drug: Busulfan;   Drug: Fludarabine
37 Not yet recruiting Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: 6-thioguanine
38 Not yet recruiting JAK-inhibition in Recurrent Classical Hodgkin Lymphoma
Condition: Recurrent Classical Hodgkin Lymphoma
Intervention: Drug: Ruxolitinib
39 Unknown  Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Condition: Lymphoma
Intervention: Drug: GemDOx
40 Recruiting Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: ofatumumab plus dexamethasone

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years